VANCOUVER, BC / ACCESSWIRE / June 8, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:PSCBF), has been awarded a grant of US$343,750 from the National Cancer Institute of ...
The implementation of a modified Skin and Ultraviolet Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) risk-based surveillance program, which included primary care, dermatology, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback